Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Re-Step: Dynamic Balance Treatment of Gait for Acquired Brain Injury (ABI) Victims

9 de marzo de 2021 actualizado por: Reuth Rehabilitation Hospital

Re-Step: a Computerized Dynamic Balance Treatment for Rehabilitation of Unassisted Gait in ABI Victims: a Prospective, Exploratory and Interventional Clinical Trial

The purpose of this study is to:

  1. Test the walking functionality of people following Acquired brain injury (ABI)
  2. Suggesting a new treatment for their walking impairments
  3. Follow-up of motor learning ability and balance after intervention within this population

The investigators intend to target dynamic stability and gait after ABI, in a group of individuals with ABI who have persistent balance and mobility deficits despite being able to walk independently and having high scores on standard clinical balance measures.

Interventions: Training with Re-Step system shoes.

In this study there is no control group.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

Study design:

Type of research: Prospective, exploratory, clinical, interventional trial

Specific objectives are:

To explore the efficacy of Re-step rehabilitation technology to improve dynamic balance in the gait of people after Acquired Brain Injury (ABI).

The investigators suggest a new technology of intervention that will induce unexpected changes of underfoot slopes, with Re-Step shoes, during walking and will force the central nervous system (CNS) to react and solve walking problems in real-time.

The investigators propose that the new approach will have a significant motor function improvement on balance in gait, transferred to real environmental settings and be retained for long periods of time.

Research methods:

Subjects:

A total of 40 subjects of ABI victims will be studied in one treatment group-Re-Step shoes walking training

Time flow protocol:

Participants will be approached using a database of hospitalized patients of Reuth Rehabilitation Hospital (Tel-Aviv, Israel) and through a call for participation placed in a newspaper.

Subjects will be recruited according to inclusion/exclusion criteria, after medical examination and given consent of participation.

Tests and measures (see outcome measures) will be applied to measure changes:

  • T1 - before starting the intervention to form a baseline
  • T2 - after 20 sessions of intensive treatments 60 min each, 2 sessions a week.
  • T3 - 6 months after T2, a period of normal daily schedule of subjects, with no interventions, to examine for retainment of training results.

The treatments will start in a week from T1; the T2 will be performed in a week after training was completed; T3 will be performed 6 months (take or leave 2 weeks) after T2.

Tipo de estudio

Intervencionista

Inscripción (Actual)

41

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Tel-Aviv, Israel, 6772829
        • Reuth Rehabilitation Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • At least one year after the Acquired brain injury.
  • Age 18 to 80 years
  • Independent walking ability for at least 10 meters
  • Patients who permanently use medications that have not been changed during the past month and with no further changes expected during the research
  • At least 19 points on the MoCA test

Exclusion Criteria:

  • Presence of degenerative neurological disability that is not secondary to the acquired brain injury
  • Other disabilities such as - severe back pain, radical active lumbosacral radicular pain, leg muscle pain, peripheral neuropathy, post-polio syndrome, rheumatic illnesses, previous orthopedic disabilities preceding or at the time of the injury that could affect the ability and pattern of walking, depression, and other neurotic syndromes including post-traumatic depression and post-traumatic stress disorder (PTSD) at a medium level or higher, chronic alcoholism and use of drugs.
  • Unstable state of health such as heart disease, respiratory insufficiency, peripheral vascular disease, acquired brain injury that has impaired walking ability
  • Inability to persevere and cooperate in the series of tests and the follow-up

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Re-Step

The system consists of a pair of special shoes which sole height and angles change in a specific given order, thereby facilitating motor learning and problem solving in real time.

This unpredictable change will introduce a situation of necessary adaptation to keep balance.

Research Group:

Each session begins with a warm-up exercise, muscle stretching, and strengthening exercises: duration 10 minutes.

Afterwards, walking exercises for 40 minutes with Re-Step according to a program individually tailored and progressing with the training. Progress is shown by an increased range of tilting of the shoe and speed of changes, according to the individual ability of each patient.

At the end of the session 10 min of cool-down exercises

22 training sessions of 60 minutes each, twice a week.

Otros nombres:
  • Step of Mind's Re-Step System shoes

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Community Balance & Mobility Scale (CB&M); Change from base line after intervention is being assessed
Periodo de tiempo: Measuring mobility ability and balance at base line and changes after intervention; and changes and rtainment of achievments 6 months of no intervention
CB&M was designed to evaluate balance and mobility in patients who, although ambulatory, have balance impairments that reduce their full engagement in community living. 13 items of dynamic balance are graded 0-5 by a physiotherapist. The CB&M is a reliable and valid clinical outcome measure for evaluating change in ability in the higher functioning ambulatory patients with TBI.
Measuring mobility ability and balance at base line and changes after intervention; and changes and rtainment of achievments 6 months of no intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
10 Meter walk Test (10MWT)
Periodo de tiempo: Measuring at base line; change immediately after intervention, and changes and retainments of achievments after 6 months
Assesses walking speed in meters per second over a short duration. The individual is instructed to walk a set distance (6 meters, 10 meters, etc). Time is measured while the individual walks the set distance (often the individual is given space to accelerate to his/her preferred walking speed (this distance is not included when determining speed). The distance covered is divided by the time it took the individual to walk that distance.
Measuring at base line; change immediately after intervention, and changes and retainments of achievments after 6 months
Montreal Cognitive Assessment (MoCA)
Periodo de tiempo: Recruitment stage

Widely used method for assessing cognitive mental status both in clinical practice and in research.

It is a brief, standardized method to grade patients' cognitive mental status. It assesses orientation, attention, immediate and short-term recall, language, and the ability to follow simple verbal and written commands. It provides a total score that places the individual on a scale of cognitive function.

The MoCA test has a high sensitivity for detecting cognitive dysfunction.

Recruitment stage
fMRI functional magnetic Resonance Imaging; Change from base line after intervention is being assessed
Periodo de tiempo: Base line brain activity; change after treatment; and change after 6 months with no interventions
Functional magnetic resonance imaging or functional MRI (fMRI) is a functional neuroimaging procedure using MRI technology that measures brain activity by detecting associated changes in blood flow. This technique relies on the fact that cerebral blood flow and neuronal activation are coupled. When an area of the brain is in use, blood flow to that region also increases.
Base line brain activity; change after treatment; and change after 6 months with no interventions

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Simona Bar-Haim, PhD; PT, The Laboratory for Rehabilitation and Motor Control of Walking Faculty of Health Sciences at Ben-Gurion University of the Negev Israel
  • Director de estudio: Jean-Jacques Vatine, Dr., Reuth Rehabilitation Hospital Tel-Aviv Israel.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de septiembre de 2014

Finalización primaria (Actual)

30 de mayo de 2018

Finalización del estudio (Actual)

30 de mayo de 2018

Fechas de registro del estudio

Enviado por primera vez

24 de julio de 2014

Primero enviado que cumplió con los criterios de control de calidad

11 de agosto de 2014

Publicado por primera vez (Estimar)

13 de agosto de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de marzo de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

9 de marzo de 2021

Última verificación

1 de marzo de 2021

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir